GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Becton Dickinson & Co (NYSE:BDX) » Definitions » Gross Margin %
中文

Becton Dickinson (Becton Dickinson) Gross Margin %

: 43.07% (As of Dec. 2023)
View and export this data going back to 1963. Start your Free Trial

Gross Margin % is calculated as gross profit divided by its revenue. Becton Dickinson's Gross Profit for the three months ended in Dec. 2023 was $2,027 Mil. Becton Dickinson's Revenue for the three months ended in Dec. 2023 was $4,706 Mil. Therefore, Becton Dickinson's Gross Margin % for the quarter that ended in Dec. 2023 was 43.07%.

Warning Sign:

Becton Dickinson & Co gross margin has been in long-term decline. The average rate of decline per year is -1.4%.


The historical rank and industry rank for Becton Dickinson's Gross Margin % or its related term are showing as below:

BDX' s Gross Margin % Range Over the Past 10 Years
Min: 41.37   Med: 45.57   Max: 50.92
Current: 41.37


During the past 13 years, the highest Gross Margin % of Becton Dickinson was 50.92%. The lowest was 41.37%. And the median was 45.57%.

BDX's Gross Margin % is ranked worse than
66.08% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.54 vs BDX: 41.37

Becton Dickinson had a gross margin of 43.07% for the quarter that ended in Dec. 2023 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Becton Dickinson was -1.40% per year.


Becton Dickinson Gross Margin % Historical Data

The historical data trend for Becton Dickinson's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Becton Dickinson Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Gross Margin %
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 47.94 42.29 45.12 44.92 42.17

Becton Dickinson Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 46.51 46.36 43.05 33.44 43.07

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Becton Dickinson's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Becton Dickinson Gross Margin % Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Becton Dickinson's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Becton Dickinson's Gross Margin % falls into.



Becton Dickinson Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Becton Dickinson's Gross Margin for the fiscal year that ended in Sep. 2023 is calculated as

Gross Margin % (A: Sep. 2023 )=Gross Profit (A: Sep. 2023 ) / Revenue (A: Sep. 2023 )
=8170 / 19372
=(Revenue - Cost of Goods Sold) / Revenue
=(19372 - 11202) / 19372
=42.17 %

Becton Dickinson's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=2027 / 4706
=(Revenue - Cost of Goods Sold) / Revenue
=(4706 - 2679) / 4706
=43.07 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Becton Dickinson  (NYSE:BDX) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Becton Dickinson had a gross margin of 43.07% for the quarter that ended in Dec. 2023 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Becton Dickinson Gross Margin % Related Terms

Thank you for viewing the detailed overview of Becton Dickinson's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Becton Dickinson (Becton Dickinson) Business Description

Address
1 Becton Drive, Franklin Lakes, NJ, USA, 07417-1880
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures pre-filled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (26% of estimated 2023 revenue) and BD Interventional (25%) account for the remainder. International revenue accounts for 43% of the company's business.
Executives
Michael David Garrison officer: EVP and President Medical BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Richard Byrd officer: EVP & President Interventional BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Claire Fraser director C/O BECTON, DICKINSON AND COMPANY, FRANKLIN LAKES NJ 07465
David Hickey officer: EVP & President, Life Sciences BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Joanne Waldstreicher director C/O STRUCTURE THERAPEUTICS INC., 611 GATEWAY BLVD, SUITE 223, SOUTH SAN FRANCISCO CA 94080
Michelle Quinn officer: EVP and Acting General Counsel 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
David Shan officer: EVP, Integrated Supply Chain 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Roland Goette officer: EVP and President, EMEA BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Christopher Delorefice officer: EVP & CFO BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Polen Thomas E Jr officer: Executive Vice President BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Samrat S. Khichi officer: EVP and General Counsel C/O CATALENT, INC., 14 SCHOOLHOUSE ROAD, SOMERSET NJ 08873
Rishi Grover officer: EVP and Chief ISC Officer BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Pavan Kumar Mocherla officer: EVP and President Greater Asia BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
James C Lim officer: Executive Vice President BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417
Thomas J Spoerel officer: VP Controller & Chief Acct Off BECTON, DICKINSON AND COMPANY, 1 BECTON DRIVE, FRANKLIN LAKES NJ 07417